Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer chemotherapy can cause permanent hair loss.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Using wigs, hairpieces, and sprays can help people with hair loss feel better about themselves.

The top research priorities for congenital ichthyosis include long-term side effects of oral retinoids, best topical treatments, and treatments for itch and hair loss.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Follicular Unit Extraction (FUE) is a popular hair transplant method with minimal scarring that can transplant many grafts quickly and improve appearance and psychological well-being.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Alopecia areata greatly affects people's life quality, mental health, and work life.

People with alopecia who are more resilient tend to feel less stressed.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

FFA's causes may include environmental triggers and genetic factors.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

Bimatoprost helped a girl grow her eyelashes back quickly and without serious side effects.

Bimatoprost gel makes eyelashes grow longer, but may cause side effects and should be monitored by an eye doctor.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The report shows a young man with Hutchinson-Gilford Progeria Syndrome had typical and additional eye problems related to the disease.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.